Avtozma

Active Ingredient(s): Tocilizumab-anoh
FDA Approved: * January 24, 2025
Pharm Company: * CELLTRION INC
Category: Arthritis

Tocilizumab, sold under the brand name Actemra among others, is an immunosuppressive drug, used for the treatment of rheumatoid arthritis and systemic juvenile idiopathic arthritis, a severe form of arthritis in children. It is a humanized monoclonal antibody against the interleukin-6 receptor (IL-6R). Interleukin 6 (IL-6) is a cytokine that plays an important role in immune response and is implicated in the pathogenesis of many diseases, such as autoimmune diseases, multiple myeloma and pros... [wikipedia]

* May have multiple approval dates, manufacturers, or labelers.

Dosage List

Avtozma 80 mg/4ml Intravenous Injection, Solution
NDC: 72606-042
Labeler:
Celltrion USA, Inc.
Avtozma 200 mg/10ml Intravenous Injection, Solution
NDC: 72606-043
Labeler:
Celltrion USA, Inc.
Avtozma 400 mg/20ml Intravenous Injection, Solution
NDC: 72606-044
Labeler:
Celltrion USA, Inc.
Avtozma 162 mg/.9ml Intravenous Injection, Solution
NDC: 72606-045
Labeler:
Celltrion USA, Inc.

Related Brands

Drugs with the same active ingredients